Given the established connection of CCN5/WISP2 with obesity, diabetes, and insulin resistance, alongside the inconsistencies in earlier research, the present study aimed to explore the association of WISP2 with risk factors in GDM patients. Here, CCN5 is linked to obesity disorder.